Mounting evidence has demonstrated that AR functions as an oncogene in ccRCC, promoting progression and hematogenous metastasis [5, 6, 22], despite the presence of few retrospective literature-based on the TCGA database implied AR may contribute to better prognosis in RCC [9]. This evidence concerns the gene AR and nonpapillary renal cell carcinoma.